Baseline observation carry forward: Reasoning, properties, and practical issues

Journal of Biopharmaceutical Statistics

Volumn 19, Issue 4, 2009, Pages 672-684

  Shao, Jun ^a   Jordan, David C ^b   Pritchett, Yili L ^b  

^a University of Wisconsin Madison   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Adverse events; Baseline observation carry forward; Dropout; Lack of efficacy; Last observation carry forward; Placebo effect

Indexed keywords

ARTICLE; DRUG EFFICACY; LONGITUDINAL STUDY; OBSERVATION; PLACEBO EFFECT; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT DURATION; TREATMENT RESPONSE;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS; LONGITUDINAL STUDIES; MODELS, STATISTICAL; PATIENT DROPOUTS; PLACEBO EFFECT; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 70449635583     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400902964118     Document Type: Article

References (13)

1. Chen, L., Li, Q. H. (2006). Assessing clinically relevant treatment differences using weighted responder means. Unpublished manuscript.
2. Cheng, B., Shao, J., Zhong, B. (2005). Last observation analysis in ANOVA and ANCOVA. Statistica Sinica 15:857-870.
3. Dawson, J. D. (1994). Stratification of summary statistic tests according to missing patterns. Statistics in Medicine 13:1853-1863.
4. Dawson, J. D., Lagakos, S. (1994). Size and power of two-sample tests of repeated measures data. Biometrics 49:1022-1032.
5. Hale, M. E., Ahdieh, H., Ma, T., Rauck, R. (2007). Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebocontrolled study. Journal of Pain 8:175-184. (Pubitemid 46186162)
6. Julius, S. A., Mullee, M. A. (2007). Issues with using baseline in last observation carried forward analysis. Pharmaceutical Statistics (www.interscience.wiley.com) DOI: 10.1002/pst.311.
7. Katz, N., Rauck, R., Ahdieh, H., Ma, T., van der Hoop, R. G., Kerwin, R., Podolsky, G. (2007). A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Current Medical Research and Opinions 23:117-128.
8. Little, R. J. (1993). Pattern-mixture models for multivariate incomplete data. Journal of the American Statistical Association 88:125-134.
9. Molenberghs, G., Kenward, M. G. (2007). Missing Data in Clinical Studies. New York: John Wiley & Sons.
10. Permutt, T., Buenconsejo, J. (2004). Responder analysis in analgesic trials: you can have it both ways. Proceedings of American Statistical Association.
11. Shao, J., Zhong, B. (2003). Last observation carry-forward and intention-to-treat analysis. Statistics in Medicine 22:2429-2441.
12. Shao, J., Zhong, B. (2006). On the treatment effect in clinical trials with dropout. J. Biopharmaceutical Statistics 16:25-33.
13. Shih, W., Quan, H. (1998). Stratified testing for treatment effects with missing data. Biometrics 54:782-787.